Catherine Alcarez Md is categorized under Internal Medicine Doctors in Atlantic City, NJ and active since 1986.
Catherine Alcarez Md was established in 1986, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Catherine Alcarez at the company’s single location by writing to 3101 Boardwalk Apartment 905, Atlantic City, New Jersey NJ 08401 or by phoning (609) 822-0179. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Catherine Alcarez Md |
| Contact Person: | Catherine Alcarez |
| Address: | 3101 Boardwalk Apartment 905, Atlantic City, New Jersey 08401 |
| Phone Number: | (609) 822-0179 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1986 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Catherine Alcarez Md was started in 1986 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Catherine Alcarez for inquiries that concern Catherine Alcarez Md by calling the company number (609) 822-0179, as your correspondence is most welcome. Additionally, the physical location of the single location of Catherine Alcarez Md can be found at the coordinates 39.350824,-74.447624 as well as the street address 3101 Boardwalk Apartment 905 in Atlantic City, New Jersey 08401.
For its online presence, you may visit Catherine Alcarez Md’s website at and engage with its social media outlets through on Twitter and on Facebook.